Cargando…
Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Geno...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821902/ https://www.ncbi.nlm.nih.gov/pubmed/35145509 http://dx.doi.org/10.3389/fimmu.2021.793992 |
_version_ | 1784646496153501696 |
---|---|
author | Pagliarulo, Fabio Cheng, Phil F. Brugger, Laurin van Dijk, Nick van den Heijden, Michiel Levesque, Mitchell P. Silina, Karina van den Broek, Maries |
author_facet | Pagliarulo, Fabio Cheng, Phil F. Brugger, Laurin van Dijk, Nick van den Heijden, Michiel Levesque, Mitchell P. Silina, Karina van den Broek, Maries |
author_sort | Pagliarulo, Fabio |
collection | PubMed |
description | Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Genome Atlas, as well as the IMvigor210 dataset to study factors associated with TLS development and function in the tumor microenvironment (TME) of MIBC. We also analyzed tumor immune composition including TLS in an independent, retrospective MIBC cohort. We found that the combination of TLS density and tumor mutational burden provides a novel independent prognostic biomarker in MIBC. Gene expression profiles obtained from intratumoral regions that rarely contain TLS in MIBC showed poor correlation with the prognostic TLS density measured in tumor periphery. Tumors with high TLS density showed increased gene signatures as well as infiltration of activated lymphocytes. Intratumoral B-cell and CD8(+) T-cell co-infiltration was frequent in TLS-high samples, and such regions harbored the highest proportion of PD-1(+)TCF1(+) progenitor-like T cells, naïve T cells, and activated B cells when compared to regions predominantly infiltrated by either B cells or CD8(+) T cells alone. We found four TLS maturation subtypes; however, differences in TLS composition appeared to be dictated by the TME and not by the TLS maturation status. Finally, we identified one downregulated and three upregulated non-immune cell-related genes in TME with high TLS density, which may represent candidates for tumor-intrinsic regulation of lymphoid neogenesis. Our study provides novel insights into TLS-associated gene expression and immune contexture of MIBC and indicates towards the relevance of B-cell and CD8(+) T-cell interactions in anti-tumor immunity within and outside TLS. |
format | Online Article Text |
id | pubmed-8821902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88219022022-02-09 Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer Pagliarulo, Fabio Cheng, Phil F. Brugger, Laurin van Dijk, Nick van den Heijden, Michiel Levesque, Mitchell P. Silina, Karina van den Broek, Maries Front Immunol Immunology Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Genome Atlas, as well as the IMvigor210 dataset to study factors associated with TLS development and function in the tumor microenvironment (TME) of MIBC. We also analyzed tumor immune composition including TLS in an independent, retrospective MIBC cohort. We found that the combination of TLS density and tumor mutational burden provides a novel independent prognostic biomarker in MIBC. Gene expression profiles obtained from intratumoral regions that rarely contain TLS in MIBC showed poor correlation with the prognostic TLS density measured in tumor periphery. Tumors with high TLS density showed increased gene signatures as well as infiltration of activated lymphocytes. Intratumoral B-cell and CD8(+) T-cell co-infiltration was frequent in TLS-high samples, and such regions harbored the highest proportion of PD-1(+)TCF1(+) progenitor-like T cells, naïve T cells, and activated B cells when compared to regions predominantly infiltrated by either B cells or CD8(+) T cells alone. We found four TLS maturation subtypes; however, differences in TLS composition appeared to be dictated by the TME and not by the TLS maturation status. Finally, we identified one downregulated and three upregulated non-immune cell-related genes in TME with high TLS density, which may represent candidates for tumor-intrinsic regulation of lymphoid neogenesis. Our study provides novel insights into TLS-associated gene expression and immune contexture of MIBC and indicates towards the relevance of B-cell and CD8(+) T-cell interactions in anti-tumor immunity within and outside TLS. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8821902/ /pubmed/35145509 http://dx.doi.org/10.3389/fimmu.2021.793992 Text en Copyright © 2022 Pagliarulo, Cheng, Brugger, van Dijk, van den Heijden, Levesque, Silina and van den Broek https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Pagliarulo, Fabio Cheng, Phil F. Brugger, Laurin van Dijk, Nick van den Heijden, Michiel Levesque, Mitchell P. Silina, Karina van den Broek, Maries Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title_full | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title_fullStr | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title_full_unstemmed | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title_short | Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer |
title_sort | molecular, immunological, and clinical features associated with lymphoid neogenesis in muscle invasive bladder cancer |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821902/ https://www.ncbi.nlm.nih.gov/pubmed/35145509 http://dx.doi.org/10.3389/fimmu.2021.793992 |
work_keys_str_mv | AT pagliarulofabio molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT chengphilf molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT bruggerlaurin molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT vandijknick molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT vandenheijdenmichiel molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT levesquemitchellp molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT silinakarina molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer AT vandenbroekmaries molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer |